BeBetter Med logo

BeBetter Med

Clinical-stage drug discovery and development of advanced novel medicines for cancer and other severe illnesses.

5 employees · est. 2012 · China

VS
Enterome logo

Enterome

Delivering the promise of immunotherapy

49 employees · est. 2011 · Paris, France

Enterome is the older company (2012 vs 2011); Enterome is the larger of the two.

Side-by-Side Comparison

BeBetter Med Enterome
Founded
2012 2011 older
Headquarters
China Paris, France
Employees
5 49 larger
Industry
Health Care, Pharmaceutical Biopharma, Biotechnology, Health Care
Funding Stage
Private Equity Series Unknown
Total Funding
$499.00M $175.80M
Funding Rounds
2 9
Services
Not tracked yet Development of off-the-shelf cancer immunotherapy treatments
Target Customers
Not tracked yet Patients with B cell malignancies, Glioblastoma, adrenal tumors, and colorectal cancer
Taxonomy
Drug Discovery, Clinical-stage, Novel Medicines, Cancer Treatment, Pharmaceutical Research, Oncology Drugs, Metabolic Disease, Clinical Development, Small Molecule Drugs, Clinical Trials, IP Rights, Guangzhou, Biopharmaceutical Company, Overseas Returnees Immunotherapy, Biopharmaceuticals, Drug Discovery, OncoMimics, Cancer Treatment, Immunomodulatory Drugs, Phase 2 Clinical Trials, Tumor Associated Antigens, CD8 T Cell Response, Glioblastoma, Adrenal Malignancies, Colorectal Cancer, Clinical-stage Biotech, Immunotherapies, Metagenomics
Website
bebettermed.cn enterome.com
BeBetter Med logo

About BeBetter Med

BeBetter Med is a rapidly growing novel drug discovery and development company based in Guangzhou, China. Founded in 2012 by overseas returnees, the company is dedicated to creating advanced novel medicines for the treatment of cancer and other severe diseases. With a focus on clinical-stage drug di...

Enterome logo

About Enterome

Enterome is a clinical-stage biopharmaceutical company founded in 2011 and headquartered in France. It focuses on delivering the promise of immunotherapy through the development of breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. The company's unique approach to d...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at BeBetter Med and Enterome — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at BeBetter Med and Enterome — by email.

Frequently Asked Questions

BeBetter Med — Clinical-stage drug discovery and development of advanced novel medicines for cancer and other severe illnesses.. Enterome — Delivering the promise of immunotherapy. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BeBetter Med has raised $499.00M while Enterome has raised $175.80M.
BeBetter Med and Enterome operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BeBetter Med with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy